众生药业(002317.SZ)：正在稳步推进昂拉地韦片的商业化工作
ZHONGSHENGYAOYEZHONGSHENGYAOYE(SZ:002317) Ge Long Hui·2025-11-21 07:27

Core Viewpoint - The company is steadily advancing the commercialization of Anglatide tablets [1] Group 1 - The company is actively engaging with investors regarding its progress in the commercialization of Anglatide tablets [1]